Zeo ScientifiX, Inc.

OTCPK:ZEOX Voorraadrapport

Marktkapitalisatie: US$13.0m

Zeo ScientifiX Beheer

Beheer criteriumcontroles 4/4

Zeo ScientifiX's CEO is Ian Bothwell, appointed in Nov 2016, has a tenure of 5.17 years. total yearly compensation is $208.32K, comprised of 80% salary and 20% bonuses, including company stock and options. directly owns 11.24% of the company’s shares, worth $1.46M. The average tenure of the management team and the board of directors is 2.2 years and 3.7 years respectively.

Belangrijke informatie

Ian Bothwell

Algemeen directeur

US$208.3k

Totale compensatie

Percentage CEO-salaris80.0%
Dienstverband CEO8yrs
Eigendom CEO11.2%
Management gemiddelde ambtstermijn2.2yrs
Gemiddelde ambtstermijn bestuur3.7yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Ian Bothwell's beloning veranderd ten opzichte van Zeo ScientifiX's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jul 31 2024n/an/a

-US$5m

Apr 30 2024n/an/a

-US$5m

Jan 31 2024n/an/a

-US$6m

Oct 31 2023US$208kUS$167k

-US$7m

Jul 31 2023n/an/a

-US$9m

Apr 30 2023n/an/a

-US$10m

Jan 31 2023n/an/a

-US$10m

Oct 31 2022US$536kUS$300k

-US$9m

Jul 31 2022n/an/a

-US$7m

Apr 30 2022n/an/a

-US$6m

Jan 31 2022n/an/a

-US$6m

Oct 31 2021US$3mUS$300k

-US$13m

Jul 31 2021n/an/a

-US$17m

Apr 30 2021n/an/a

-US$21m

Jan 31 2021n/an/a

-US$20m

Oct 31 2020US$2mUS$300k

-US$13m

Jul 31 2020n/an/a

-US$8m

Apr 30 2020n/an/a

-US$3m

Jan 31 2020n/an/a

-US$2m

Oct 31 2019US$277kUS$277k

-US$2m

Jul 31 2019n/an/a

-US$1m

Apr 30 2019n/an/a

-US$1m

Jan 31 2019n/an/a

-US$4m

Oct 31 2018US$843kUS$252k

-US$3m

Compensatie versus markt: Ian's total compensation ($USD208.32K) is below average for companies of similar size in the US market ($USD655.65K).

Compensatie versus inkomsten: Ian's compensation has been consistent with company performance over the past year.

CEO

Ian Bothwell (64 yo)

8yrs

Tenure

US$208,315

Compensatie

Mr. Ian T. Bothwell has been the Chief Financial Officer of Zeo ScientifiX, Inc. (formerly known as Organicell Regenerative Medicine, Inc.) since November 4, 2016 and serves as its Director since September...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Ian Bothwell
Interim CEO8yrsUS$208.32k11.24%
$ 1.5m
George Shapiro
Chief Medical Officer & Director6.2yrsUS$100.00k6.12%
$ 794.0k
Jackie Domenech
Vice President of Operation1.8yrsgeen gegevensgeen gegevens
David Aciego
Chief Information Officer2.2yrsgeen gegevensgeen gegevens
Jill Swartz
Chief Product Officer1.8yrsgeen gegevensgeen gegevens

2.2yrs

Gemiddelde duur

Ervaren management: ZEOX's management team is considered experienced (2.2 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Ian Bothwell
Interim CEO5.2yrsUS$208.32k11.24%
$ 1.5m
George Shapiro
Chief Medical Officer & Director5.8yrsUS$100.00k6.12%
$ 794.0k
Gurvinder Pal Singh
Independent Director2.2yrsgeen gegevens0%
$ 0
Chuck Bretz
Independent Chairman of the Board2.2yrsgeen gegevens0%
$ 0
Bryan Kelly
Member of Medical Advisory Boardno datageen gegevensgeen gegevens
Carolyn DeLucia
Member of Medical Advisory Boardno datageen gegevensgeen gegevens
Paul Thompson
Member of Medical Advisory Boardno datageen gegevensgeen gegevens
Paul Campion
Member of Medical Advisory Boardno datageen gegevensgeen gegevens
Marianne La Barbera
Member of Medical Advisory Boardno datageen gegevensgeen gegevens
Sonita Sadio
Member of Medical Advisory Boardno datageen gegevensgeen gegevens
Henry Sobo
Member of Medical Advisory Boardno datageen gegevensgeen gegevens
Rolf Wallin
Member of Medical Advisory Boardno datageen gegevensgeen gegevens

3.7yrs

Gemiddelde duur

63.5yo

Gemiddelde leeftijd

Ervaren bestuur: ZEOX's board of directors are considered experienced (3.7 years average tenure).